2021

1. DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis

   Journal of Medicinal Chemistry, Vol. 64, Núm. 21, pp. 16159-16176

2. Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial

   Cell Chemical Biology, Vol. 28, Núm. 5, pp. 711-721.e8